JW Pharmaceutical Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - JW Pharmaceutical Corp

Watchlist Manager

Watchlist

Price: 27 500 KRW 1.29% Market Closed

Market Cap: ₩655.6B

	JW Pharmaceutical Corp KRX:001060	KR
	China SXT Pharmaceuticals Inc NASDAQ:SXTC	CN
	BEST Inc NYSE:BEST	CN
	Argosy Property Ltd NZX:ARG	NZ
V	Vietnam Export Import Commercial Joint Stock Bank VN:EIB	VN
A	Advanced Micro Devices Inc BMV:AMD	US
	CAMP4 Therapeutics Corp NASDAQ:CAMP	US

Profitability Summary

JW Pharmaceutical Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

45%

Gross Margin is Increasing

44% > 47%

Healthy Operating Margin

13%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

11% > 13%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 8%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

3% > 6%

Positive ROE

19%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

ROIC is Increasing

14% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.